GoodRx Holdings Inc
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
GDRX$3.65+4.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| (in thousands, except par values) | December 31, 2024 | December 31, 2023 |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $448,346 | $672,296 |
| Accounts receivable, net | 145,934 | 143,608 |
| Prepaid expenses and other current assets | 64,975 | 56,886 |
| Total current assets | 659,255 | 872,790 |
| Property and equipment, net | 12,664 | 15,932 |
| Goodwill | 410,769 | 410,769 |
| Intangible assets, net | 52,102 | 60,898 |
| Capitalized software, net | 124,781 | 95,439 |
| Operating lease right-of-use assets, net | 27,794 | 29,929 |
| Deferred tax assets, net | 77,182 | 65,268 |
| Other assets | 23,520 | 37,775 |
| Total assets | $1,388,067 | $1,588,800 |
| Liabilities and stockholders' equity | ||
| Current liabilities | ||
| Accounts payable | $14,137 | $36,266 |
| Accrued expenses and other current liabilities | 99,130 | 71,329 |
| Current portion of debt | 5,000 | 8,787 |
| Operating lease liabilities, current | 5,636 | 6,177 |
| Total current liabilities | 123,903 | 122,559 |
| Debt, net | 486,711 | 647,703 |
| Operating lease liabilities, net of current portion | 46,040 | 48,403 |
| Other liabilities | 6,755 | 8,177 |
| Total liabilities | 663,409 | 826,842 |
| Commitments and contingencies (Note 13) | ||
| Stockholders' equity | ||
| Preferred stock, $0.0001 par value; 50,000 shares authorized and nil shares issued and outstanding at December 31, 2024 and December 31, 2023 | — | — |
| Common stock, $0.0001 par value; Class A: 2,000,000 shares authorized, 105,946 and 92,355 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively; and Class B: 1,000,000 shares authorized, 276,869 and 301,732 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively | 38 | 40 |
| Additional paid-in capital | 2,165,633 | 2,219,321 |
| Accumulated deficit | (1,441,013) | (1,457,403) |
| Total stockholders' equity | 724,658 | 761,958 |
| Total liabilities and stockholders' equity | $1,388,067 | $1,588,800 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.